Clinical Trials Browser

Phase 3 × Adenocarcinoma Of Esophagus × Ipilimumab × Clear all

NCT02872116 2025-08-07

CheckMate649

Phase 3 Completed

2,031 enrolled 19 charts 1 FDA

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms